Funding Received
$534.3 Million in 8 Rounds from 10 Investors
Most Recent Funding
$200 Million Private Equity on April 1, 2014
Founded:
1997
Headquarters:
Hayward, CA
Description:
Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.
Categories:
Biotechnology
Website:
http://www.intarcia.com

Detailed Description

Update

Intarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The company’s products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.

Current Team (10)

Update

Past Team (3)

Update

Board Members and Advisors (4)

Update

Investors (10)

Update

Offices/Locations (2)

Update
  • Headquarters

    155 Seaport Boulevard

    11th Floor

    Boston, MA 02210

    USA

  • Office

    24650 Industrial Boulevard

    Hayward, CA 94545

    USA

Images (1)

Update
  • Bp6pdntb9omxc9awwduo